It has been demonstrated that the glycolysis rate‐limiting enzyme hexokinase 2 (HK2) is highly expressed in newly diagnosed MM (NDMM) patients, it is increased along disease progression, and it is associated with poor prognosis.11, 12. The gene discussed is HK2; the disease is Miyoshi myopathy.